15 ML tremelimumab-actl 20 MG/ML Injection
RxNorm concept 2619317, clinical drug (scd). Prescribable name: tremelimumab-actl 300 MG in 15 ML Injection.
- RxCUI
- 2619317
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2619317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
tremelimumab-actl 20 MG/ML per 15 ML Injection; tremelimumab-actl 300 MG per 15 ML Injection
Related concepts
- tremelimumab-actl 20 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 15 ML tremelimumab-actl 20 MG/ML Injection [Imjudo] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2619317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2619317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2619317. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.